| Filed On | Filing |
|---|---|
| 05 Oct 2026 |
8-K: Regulation FD Disclosure
The BB-301 pivotal trial remains on track to begin in mid-2027 |
| 30 Sep 2026 |
8-K: Changes in Registrant's Certifying Accountant
As previously disclosed on a Current Report on Form 8-K with the Securities and Exchange Commission that Benitec Biopharma Inc. (the “Company”) filed on September 24, 2026, the Company reported the approval of the engagement of Ernst & Y... |
| 24 Sep 2026 |
8-K: Changes in Registrant's Certifying Accountant
We are the former independent registered public accounting firm for Benitec Biopharma Inc. (the “Company”). We have read the Company’s disclosure set forth in Item 4.01 “Changes in Registrant’s Certifying Accountant” of the Company’s Cur... |
| 14 Sep 2026 |
8-K: Results of Operations and Financial Condition
All six Cohort 1 (low dose BB-301) patients have completed the full 12-month post-treatment follow-up period, and Cohort 2 (high dose BB-301) is fully enrolled with all three patients having been safely treated |
| 29 May 2026 | 8-K: Departure/Election of Directors or Officers; Compensation |
| 14 May 2026 | 8-K: Results of Operations and Financial Condition |
| 12 Feb 2026 | 8-K: Results of Operations and Financial Condition |
| 02 Dec 2025 | 8-K: Submission of Matters to a Vote of Security Holders |
| 14 Nov 2025 | 8-K: Results of Operations and Financial Condition |
| 07 Nov 2025 | 8-K: Entry into a Material Definitive Agreement; Other Events |
| 03 Nov 2025 | 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure +1 more |
| 22 Sep 2025 | 8-K: Results of Operations and Financial Condition |
| 12 Sep 2025 | 8-K: Non-Reliance on Previously Issued Financial Statements |
| 09 Jul 2025 | 8-K: Regulation FD Disclosure |
| 14 May 2025 | 8-K: Results of Operations and Financial Condition |
| 28 Mar 2025 | 8-K: Other Events |
| 27 Mar 2025 | 8-K: Entry into a Material Definitive Agreement |
| 26 Mar 2025 | 8-K: Entry into a Material Definitive Agreement; Other Events |
| 20 Mar 2025 | 8-K: Other Events |
| 19 Mar 2025 | 8-K: Regulation FD Disclosure |
Loading...
